Dolby Laboratories, Inc.
DLB
$54.06
-$0.06-0.11%
NYSE
| 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.06% | -8.43% | -2.60% | 24.39% | 34.79% |
| Total Depreciation and Amortization | 7.79% | 9.45% | 12.91% | 12.85% | 5.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.71% | 42.48% | 52.54% | 9.81% | -12.22% |
| Change in Net Operating Assets | -276.95% | -109.69% | 75.50% | 84.67% | -279.87% |
| Cash from Operations | -19.39% | -1.27% | 44.29% | 57.22% | 5.85% |
| Capital Expenditure | -26.84% | -11.44% | -21.13% | 10.81% | 6.35% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 99.72% | -- | -2,003.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.74% | -92.83% | -95.58% | 1,899.88% | 2,594.79% |
| Cash from Investing | 70.88% | 99.59% | 96.30% | -459.31% | -1,584.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.13% | -18.76% | 6.77% | -22.38% | -34.49% |
| Repurchase of Common Stock | -72.61% | -63.89% | 18.38% | 28.25% | 27.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.29% | -10.05% | -10.49% | -10.58% | -10.79% |
| Other Financing Activities | 86.87% | 88.81% | 87.76% | -166.83% | -1,334.38% |
| Cash from Financing | -43.80% | -41.43% | 14.10% | 10.05% | 3.20% |
| Foreign Exchange rate Adjustments | 712.77% | 214.77% | -81.40% | 494.04% | 26.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.41% | 219.49% | 189.76% | -7.43% | -156.53% |